In contrast, the PEPT2*2/2 haplotype was less common among patients with encephalopathy and/or polyneuropathy compared to PEPT2*1/2 haplotype in our series, but more common in patients with chronic kidney disease. This evidence concerns the gene SLC15A2 and chronic kidney disease.